HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angel Chao Selected Research

Salvage Therapy

6/2014Treatment failure in endometrial carcinoma.
10/2010Long-term follow up of cervical cancer patients with unexplained squamous cell carcinoma antigen elevation after post-therapy surveillance using positron emission tomography.
1/200618F-FDG PET in the management of endometrial cancer.
10/2004Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
7/2004Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angel Chao Research Topics

Disease

48Neoplasms (Cancer)
05/2024 - 08/2002
23Endometrial Neoplasms (Endometrial Cancer)
02/2022 - 01/2006
16Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 04/2004
14Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 09/2010
11Carcinoma (Carcinomatosis)
10/2023 - 07/2004
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 05/2009
7Endometriosis
11/2021 - 11/2008
5Neoplasm Metastasis (Metastasis)
11/2021 - 09/2007
4Uterine Cervical Dysplasia
07/2012 - 04/2004
3Adenomyosis
12/2023 - 01/2018
3Carcinogenesis
01/2021 - 02/2013
3Cicatrix (Scar)
01/2018 - 07/2005
3Infections
01/2012 - 07/2009
3Fever (Fevers)
10/2009 - 08/2002
2Hypoxia (Hypoxemia)
11/2023 - 01/2008
2Endometrial Hyperplasia
02/2022 - 01/2022
2Lymphatic Metastasis
11/2021 - 11/2010
2Disease Progression
07/2021 - 12/2014
2Myoma
07/2020 - 01/2018
2Uterine Hemorrhage (Uterine Bleeding)
02/2011 - 07/2005
2Choriocarcinoma
05/2010 - 08/2002
2Abscess
07/2009 - 08/2002
1COVID-19
04/2024
1Hyperandrogenism
11/2023
1Virilism (Virilization)
11/2023
1Lung Neoplasms (Lung Cancer)
10/2023
1Hypopharyngeal Neoplasms
09/2023
1Squamous Cell Carcinoma of Head and Neck
09/2023
1Hyperplasia
02/2022
1Leiomyoma (Uterine Fibroids)
01/2022
1Carcinosarcoma
11/2021

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
09/2023 - 07/2009
10DNA (Deoxyribonucleic Acid)IBA
11/2023 - 04/2004
10PhosphoproteinsIBA
03/2021 - 09/2010
6RNA (Ribonucleic Acid)IBA
11/2023 - 07/2006
6Biomarkers (Surrogate Marker)IBA
02/2022 - 09/2010
5Formaldehyde (Formol)FDA Link
11/2023 - 05/2010
5ParaffinIBA
11/2023 - 05/2010
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 10/2004
4Tumor Biomarkers (Tumor Markers)IBA
12/2023 - 10/2004
4Estrogens (Estrogen)FDA Link
09/2016 - 01/2012
3Acetates (Acetic Acid Esters)FDA Link
04/2024 - 09/2016
3Peptides (Polypeptides)IBA
12/2023 - 08/2016
3MicroRNAs (MicroRNA)IBA
02/2022 - 05/2010
3AntigensIBA
11/2021 - 06/2013
3NucleophosminIBA
01/2021 - 02/2013
3Estrogen ReceptorsIBA
07/2019 - 01/2013
3Phosphotransferases (Kinase)IBA
09/2014 - 08/2012
3squamous cell carcinoma-related antigenIBA
11/2010 - 07/2004
3Anti-Bacterial Agents (Antibiotics)IBA
10/2009 - 08/2002
2SteroidsIBA
11/2023 - 02/2013
2palbociclibIBA
11/2021 - 07/2019
2LuciferasesIBA
03/2021 - 04/2018
2AntibodiesIBA
03/2021 - 01/2013
2Lysine (L-Lysine)FDA Link
03/2021 - 09/2017
2VaccinesIBA
01/2021 - 02/2011
2Tyrosine Kinase InhibitorsIBA
01/2020 - 09/2014
2PlatinumIBA
01/2018 - 02/2016
2Cisplatin (Platino)FDA LinkGeneric
06/2017 - 02/2016
2LipidsIBA
01/2017 - 07/2009
2Hormones (Hormone)IBA
09/2016 - 02/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2016 - 08/2012
2activin receptor type II-A (activin A receptor, type II)IBA
01/2013 - 08/2012
1mRNA VaccinesIBA
04/2024
1Urea (Carbamide)FDA LinkGeneric
04/2024
1Nucleic AcidsIBA
11/2023
1Circulating Tumor DNAIBA
10/2023
1Monoclonal AntibodiesIBA
10/2023
1durvalumabIBA
10/2023
1pembrolizumabIBA
10/2023
1B7-H1 AntigenIBA
10/2023
1atezolizumabIBA
10/2023
1Immune Checkpoint InhibitorsIBA
10/2023
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
09/2023
1Genetic Markers (Genetic Marker)IBA
09/2023
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022
1PlasticsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1InterferonsIBA
11/2021
1lenvatinibIBA
11/2021
1Therapeutic UsesIBA
11/2021

Therapy/Procedure

15Therapeutics
05/2024 - 09/2007
10Drug Therapy (Chemotherapy)
10/2023 - 08/2002
7Hysterectomy
12/2023 - 08/2002
5Chemoradiotherapy
01/2024 - 09/2016
5Salvage Therapy
06/2014 - 07/2004
4Adjuvant Chemotherapy
11/2021 - 10/2016
4Aftercare (After-Treatment)
04/2020 - 02/2007
3Uterine Myomectomy
01/2022 - 01/2018
3Radiotherapy
03/2014 - 11/2010
2Cell- and Tissue-Based Therapy (Cell Therapy)
12/2023 - 10/2014
2Immunotherapy
12/2023 - 01/2021
2Cytoreduction Surgical Procedures
07/2021 - 01/2018
2Neoadjuvant Therapy
07/2021 - 06/2017
2Laparotomy
04/2021 - 11/2008
2Length of Stay
01/2018 - 10/2009
2Cesarean Section (Caesarean Section)
03/2013 - 02/2011
2Conservative Treatment
03/2011 - 10/2010
2Cystectomy
10/2010 - 11/2008
1Uterine Artery Embolization
01/2022